Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02922881 · ClinicalTrials.gov registry record · NA
Microbiota-targeted Diet for Pediatric UC
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02922881: Completed NA study, sponsored by Children's Hospital of Philadelphia.
NCT02922881 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02922881, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Ulcerative colitis is a chronic inflammatory disease primarily involving the colon and has long been considered to be due to a dysregulated immune response targeting the colon, and involves unknown environmental factors. Currently, no effective therapy targets the microbiota or its interaction with the colonic epithelium. Diet has a significant impact on the composition of the microbiota; however, no dietary intervention to date has proven effective for induction of remission. The primary objective of this study is to determine whether the Ulcerative Colitis Diet (UCD) can induce remission or response in pediatric UC patients with active mild to moderate UC on a stable medication.
Primary Outcome
Remission defined by the Pediatric Ulcerative Colitis Activity Index (PUCAI)
Interventions
- OTHER Ulcerative Colitis Diet (UCD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT02922881 record still lists
NCT02922881 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Ulcerative Colitis Diet (UCD) is the first listed.
NCT02922881 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02922881 about?
NCT02922881 is a clinical study titled "Microbiota-targeted Diet for Pediatric UC". Ulcerative colitis is a chronic inflammatory disease primarily involving the colon and has long been considered to be due to a dysregulated immune response targeting the colon, and involves unknown environmental factors. Currently, no effective therapy targets the microbiota or its interaction with ...
What is the current status of trial NCT02922881?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2017-03-08. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT02922881?
The interventions under investigation include: Ulcerative Colitis Diet (UCD) (OTHER).
Who is sponsoring clinical trial NCT02922881?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02922881's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI